Enveric Envisions Using Mushrooms and Cannabis to Help Patients

  • 05/26/2021
  • Source: Real Money
  • by: Debra Borchardt
Enveric Envisions Using Mushrooms and Cannabis to Help Patients
Cannabinoid biotech company Enveric Biosciences Inc. (ENVB) recently decided to expand its product offering to its targeted patient group by bringing psychedelic medicine company MagicMed into its fold.

Enveric acquired privately held MagicMed recently in a deal valued at $30 million. Enveric's CEO David Johnson is moving into the Chairman role, while MagicMed's leader, Dr. Joseph Tucker, will be named the new CEO of the combined company.

I had the chance to speak with Dr. Tucker and find out why this cannabis biotech company felt the need to expand into psychedelics.

Exclusives

Responsive image
Easy Money in Colombia Oil Patch?

Oil & gas prices are up. But many O&G stocks have yet to follow. Where should investors look for value opportunities?

Gold Is Glittering Again
Wall Street Hates These Stocks
Gold Bull Run Has Begun
Copper Setting Up For Major Run
DYNAMIC WEALTH RESEARCH

Analysis and insights into the newest trends and industries shaping the world and your wealth.

The world is more dynamic than at any time in History.
New Markets are opening up. Technology is accelerating. It’s changing everything.

And creating fortunes in the process.

Dynamic Wealth Research exposes the biggest and most profitable changes for our readers.

Recent News

Responsive image
RUA GOLD Provides an Update on the Reefton Drilling Program and the next phase of drill targets
Responsive image
Easy Money in Colombia Oil Patch?
Responsive image
Gold Is Glittering Again
SHARE DYNAMIC WEALTH RESEARCH
© 2016 - 2024 DYNAMIC WEALTH RESEARCH, Privacy Policy, Disclaimer
powered by structure cms™